Hypha Labs, Inc. · OTC:FUNI
Hypha Labs — Investor Presentation (March 2026)
14 slides from Hypha Labs's investor presentation, March 2026
Slide 1: The Myco-Revolution Begins Now
STRATEGIC PARTNERSHIP · PATENT PENDING TECHNOLOGY · MARCH 2026 THE MYCO- REVOLUTION BEGINS NOW H YPH A LABS, IN C. OT CQB : FUNI × MYCOLOGY RESOURCES, LLC L AKE E L SINORE , CA Patent Pending technology meets proven global distribution. The commercial scaling of Micropearls™ disrupts everything. 76B
Slide 2: The Problem: An Industry Frozen in Time
THE PROBLEM: AN INDUSTRY FROZEN IN TIME A $76 BILLION MARKET HELD HOSTAGE BY 19TH-CENTURY PRODUCTION METHODS GLOBAL MARKET PROJECTION (2033) 76.35 Billion The functional mushroom industry is one of the fastest- growing sectors in global wellness, yet it remains shackled by production methods that ar
Slide 3: The Solution: Two Innovators, One Unstoppable Force
THE SOLUTION: TWO INNOVATORS, ONE UNSTOPPABLE FORCE PATENT PENDING TECHNOLOGY MEETS GLOBAL DISTRIBUTION HYPHA LABS MYCOLOGY RESOURCES Patent Pending Technology AI-driven Mushroom Accelerator™ & proprietary Micropearls™ delivery system. Rapid Production Revolutionary 8-day production cycle vs. months
Slide 4: The Product: Micropearls™
THE PRODUCT: MICROPEARLS™ TASTELESS, ODORLESS, AND SCIENTIFICALLY SUPERIOR — THE NEW GOLD STANDARD Micropearls™ represent a paradigm shif t in 01 8-DAY PRODUCTION CYCLE Vs. 6–16 weeks for traditional methods functional wellness. Unlike pills, powders, and tinctures that 02 TASTELESS & ODORLESS Disso
Slide 5: The Market: Distribution Deals Are Already in Place
THE MARKET: DISTRIBUTION DEALS ARE ALREADY IN PLACE WE ARE NOT WAITING FOR CUSTOMERS — THE CUSTOMERS ARE WAITING FOR US The most powerful de-risking factor in this JAPAN MARKET EXPORT CHANNELS ACTIVE partnership is simple: Mycology Resources has 4.92 Billion already secured the distribution. Project
Slide 6: The Revenue Model: 50/50 Net Profit Sharing
THE REVENUE MODEL: 50/50 NET PROFIT SHARING EVERY MICROPEARL™ SOLD PUTS MONEY DIRECTLY INTO HYPHA LABS' POCKET Under the de nitive partnership agreement, Hypha Labs receives 50% of the net pro ts from all global Micropearls™ sales. This is a contractually guaranteed, recurring revenue stream that tr
Slide 7: The Technology Moat: Patents Protect the Advantage
THE TECHNOLOGY MOAT: PATENTS PROTECT THE ADVANTAGE A PATENT PENDING PORTFOLIO THAT COMPETITORS CANNOT REPLICATE AI-Driven Optimization Algorithms Cloud-connected IoT sensor system for real-time growth optimization. Proprietary Sterile Cartridge System Enables the "Razor/Blade" recurring revenue mode
Slide 8: The Industry Disruption: This Changes How Mushrooms Are Made Forever
THE INDUSTRY DISRUPTION: THIS CHANGES HOW MUSHROOMS ARE MADE FOREVER THIS IS NOT AN IMPROVEMENT. THIS IS A REPLACEMENT OF EVERYTHING THAT CAME BEFORE. FACTOR TRADITIONAL METHOD HYPHA LABS + MYCOLOGY RESOURCES Production Cycle 6–16 Weeks 8 Days Infrastructure Cost High (HEPA labs, equipment) Modular,
Slide 9: The Japan Opportunity: A Premium Market That Already Knows Us
THE JAPAN OPPORTUNITY: A PREMIUM MARKET THAT ALREADY KNOWS US JAPAN'S $4.9 BILLION MUSHROOM MARKET IS NOT A FUTURE TARGET — IT IS A CURRENT CUSTOMER 4.92B Japan is arguably the most sophisticated market for functional mushrooms in the world. PROJECTED MARKET SIZE (2030) Consumers place an extraordin
Slide 10: The Capital Raise: Fund the Engine, Reap the Rewards
THE CAPITAL RAISE: FUND THE ENGINE, REAP THE REWARDS THIS ROUND FUNDS PRODUCTION — NOT PROMISES. THE REVENUE STARTS WHEN THE ACCELERATOR STARTS. The capital raised will be deployed with surgical precision: 50% to Hypha Labs for public company infrastructure and compliance, and 50% to Mycology Resour
Slide 11: The Team: Proven Operators, Not First-Time Founders
THE TEAM: PROVEN OPERATORS, NOT FIRST-TIME FOUNDERS THE PEOPLE BEHIND THE MYCO-REVOLUTION HAVE DONE THIS BEFORE The combined team represents a rare convergence of scienti c innovation, commercial execution, and global market knowledge. HYPHA LABS LEADERSHIP MYCOLOGY RESOURCES LEADERSHIP BIOTECHNOLOG
Slide 12: The Milestones: A Clear Roadmap
THE MILESTONES: A CLEAR ROADMAP FROM CAPITAL CLOSE TO FIRST MICROPEARLS™ SALE — A DEFINED, MEASURABLE PATH MONTH 1–2 Close capital raise; execute commercial accelerator engineering contracts MONTH 2–4 Site preparation and equipment procurement complete MONTH 4–6 Commercial Mushroom Accelerator opera
Slide 13: The Closing: The Revolution Will Not Wait
THE CLOSING: THE REVOLUTION WILL NOT WAIT THE MARKET IS READY. THE TECHNOLOGY IS READY. THE DISTRIBUTION IS READY. ARE YOU? ✓ ✓ ✓ MARKET TECHNOLOGY DISTRIBUTION V AL I D ATE D PATE N T PE N D I N G S E CURE D We have done the hard work. We have secured the deals. We have built the technology. Now we
Slide 14: Appendix: Market Data Sources
APPENDIX: MARKET DATA SOURCES DATA SUPPORTING THE $76 BILLION OPPORTUNITY STRAITS RESEARCH GRAND VIEW RESEARCH "Functional Mushroom Market Size, Growth & Trends "Japan Functional Mushroom Market Size & Outlook, Forecast by 2033" 2030" Primary source for global market projection of $76.35 billion. So